Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interferon gamma receptor 2 (IFNGR2) is a critical component of the interferon-gamma (IFN-γ) receptor complex. It is the non-ligand-binding beta chain and plays an essential role in immune signaling and host defense by enabling signal transduction through the JAK/STAT pathway. Mutations in IFNGR2 cause autosomal recessive Mendelian susceptibility to mycobacterial disease (MSMD).
Enables signal transduction via JAK/STAT pathway upon interferon-gamma binding to IFNGR1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon gamma receptor 2 (IFNGR2).